Zurletrectinib has been included in the “SPARK Program” by China’s National Medical Products Administration (NMPA), a pilot initiative to encourage the development of pediatric anti-tumor drugs.
Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial growth ...
ADB approves US$500 million loan to bolster Philippines’ blue-economy reforms. Find the latest news from the maritime industry on the PortNews website.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback